Parkville, Australia

Paul Anthony Stupple

This inventor holds 6 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 16 EPO patents. Top assignees: Ctxt Pty Limited, Pfizer Corporation. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Anthony Stupple. Retrieved from https://idiyas.com/inventor/paul-anthony-stupple-cqpynnz2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.1

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Paul Anthony Stupple: Pioneering Cancer Treatment Solutions

Introduction: Paul Anthony Stupple, an esteemed inventor based in Parkville, Australia, has made significant contributions to the field of pharmaceuticals. With a portfolio of three patents, he has demonstrated his commitment to advancing medical science and improving patient outcomes. His innovative work primarily focuses on treatments for abnormal cell growth, including cancer.

Latest Patents: Among his latest notable inventions is a patent for benzisoxazole sulfonamide derivatives. This invention encompasses compounds that are effective in treating abnormal cell growth in patients. Specifically, the patent details compounds of formula (I) or pharmaceutically acceptable salts, where specific components such as Ring A, R-R, and n are defined in further detail. These novel derivatives not only provide therapeutic potential against cancer but also include pharmaceutical compositions that utilize these compounds and methods for their application in treatment practices.

Career Highlights: Throughout his career, Paul Anthony Stupple has been associated with renowned companies in the pharmaceutical sector, including Ctxt Pty Limited and Pfizer Corporation. His experiences in these organizations have enriched his knowledge and expertise, enabling him to develop innovative solutions for complex health challenges.

Collaborations: Paul has collaborated with notable colleagues in his field, including Michelle Ang Camerino and Ylva Elisabet Bergman Bozikis. These collaborations have fostered a rich environment of shared ideas and joint ventures, enhancing the scope and impact of his inventions.

Conclusion: As an inventor, Paul Anthony Stupple continues to make strides in the pharmaceutical industry. His dedication to developing effective treatments for cancer and other serious health conditions reflects his innovative spirit and commitment to advancing medical science. Through his patents and collaborative efforts, Stupple embodies the essence of invention that can lead to transformative changes in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…